Skip to main content

Ginger Clark, MD, MS : Research

Gastroenterologist, Transplant Hepatologist

Rated 5.0 out of 5 stars
Photo of Ginger Clark

Research at a glance

Top areas of exploration

  • Liver Cirrhosis , 8 publications
  • Hepatitis C , 8 publications
  • alpha 1-Antitrypsin Deficiency , 6 publications
  • Antiviral Agents , 6 publications

Research activity

42 publications

1,422 citations

Why is this important?

Active clinical trials

Takeda TAK-999-3001

The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get information on how fazirsiran affects the body…

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All

My publications

42 publications

2024

Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.

Alimentary pharmacology & therapeutics

PubMed Publisher's site

2021

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.

Journal of hepatology

PubMed Publisher's site

2021

Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens.

PloS one

PubMed Publisher's site